1,776
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Chinese herbal compound Huangqin Qingrechubi capsule reduces lipid metabolism disorder and inflammatory response in gouty arthritis via the LncRNA H19/APN/PI3K/AKT cascade

, , , , &
Pages 541-555 | Received 20 Oct 2022, Accepted 12 Mar 2023, Published online: 30 Mar 2023

References

  • Butler F, Alghubayshi A, Roman Y. 2021. The epidemiology and genetics of hyperuricemia and gout across major racial groups: a literature review and population genetics secondary database analysis. JPM. 11(3):231–245.
  • Chen S, Chen D, Yang H, Wang X, Wang J, Xu C. 2020. Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis. BMC Gastroenterol. 20(1):39–47.
  • Choi HM, Doss HM, Kim KS. 2020. Multifaceted physiological roles of adiponectin in inflammation and diseases. IJMS. 21(4):1219–1241.
  • Chaussade C, Rewcastle GW, Kendall JD, Denny WA, Cho K, Grønning LM, Chong ML, Anagnostou SH, Jackson SP, Daniele N, et al. 2007. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem J. 404(3):449–458.
  • Chen XX, Wang KW, Lu T, Wang JJ, Zhou T, Tian J, Zhou B, Long L, Zhou Q. 2022. Adiponectin is negatively associated with disease activity and Sharp score in treatment-naïve Han Chinese rheumatoid arthritis patients. Sci Rep. 12(1):2092–2098.
  • Dehlin M, Jacobsson L, Roddy E. 2020. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 16(7):380–390.
  • Duan H, Khan GJ, Shang LJ, Peng H, Hu WC, Zhang JY, Hua J, Cassandra A, Rashed MMA, Zhai KF. 2021. Computational pharmacology and bioinformatics to explore the potential mechanism of Schisandra against atherosclerosis. Food Chem Toxicol. 150:112058.
  • Diaz-Torne C, Ortiz MA, Garcia-Guillen A, Jeria-Navarro S, Sainz L, Fernandez-Sanchez S, Corominas H, Vidal S. 2021. The inflammatory role of silent urate crystal deposition in intercritical gout. Rheumatology. 60(11):5463–5472.
  • Engin A. 2017. Adiponectin-Resistance in obesity. Adv Exp Med Biol. 960:415–441.
  • Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, Esquivel-Soto J, Morales-González A, Esquivel-Chirino C, Durante-Montiel I, Sánchez-Rivera G, Valadez-Vega C, Morales-González JA. 2011. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 12(5):3117–3132.
  • Fu X, Song G, Ni R, Liu H, Xu Z, Zhang D, He F, Huang G. 2021. LncRNA-H19 silencing suppresses synoviocytes proliferation and attenuates collagen-induced arthritis progression by modulating miR-124a. Rheumatology. 60(1):430–440.
  • Haagenson KK, Wu GS. 2010. The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment. Cancer Metastasis Rev. 29(1):143–149.
  • Kwon M, Kim Y, Lee J, Manthey JA, Kim Y, Kim Y. 2022. Neohesperidin dihydrochalcone and neohesperidin dihydrochalcone-O-glycoside attenuate subcutaneous fat and lipid accumulation by regulating PI3K/AKT/mTOR pathway in vivo and in vitro. Nutrients. 14(5):1087–1104.
  • Lei Y, Cui Q, Yang G, Piao L, Inoue A, Wu H, Li X, Kuzuya M, Cheng XW. 2021. Statins mitigate stress-related vascular aging and atherosclerosis in apoE-deficient mice fed high fat-diet: the role of glucagon-like peptide-1/adiponectin axis. Front Cell Dev Biol. 9:687868.
  • Liu Y, Liu C, Jiang C, Wang S, Yang Q, Jiang D, Yuan G. 2016. C-reactive protein inhibits high-molecular-weight adiponectin expression in 3T3-L1 adipocytes via PI3K/Akt pathway. Biochem Biophys Res Commun. 472(1):19–25.
  • Liu L, Xue Y, Zhu YF, Xuan DD, Yang X, Liang MR, Wang J, Zhu XX, Zhang J, Zou HJ. 2016. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout. Arthritis Res Ther. 18(1):268–281.
  • Lou D, Zhang X, Jiang C, Zhang F, Xu C, Fang S, Shang X, Zhang J, Yin Z. 2022. 3β,23-Dihydroxy-12-ene-28-ursolic acid isolated from Cyclocarya paliurus alleviates NLRP3 inflammasome-mediated gout via PI3K-AKT-mTOR-dependent autophagy. Evid Based Complement Alternat Med. 2022:1–15.
  • Marchese FP, Raimondi I, Huarte M. 2017. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 18(1):206–218.
  • Marques-Rocha JL, Samblas M, Milagro FI, Bressan J, Martínez JA, Marti A. 2015. Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J. 29(9):3595–3611.
  • Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. 1992. Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol. 149(4):1424–1431.
  • Mu Z, Wang J, Wang W, Lv W, Chen Y, Wang F, Zhao Y, Dong B, Wang Y, Wang Z. 2020. Blood glucose fluctuations detected by continuous glucose monitoring system in gout patients with normal glucose tolerance and the effect of urate-lowering therapy. Int J Rheum Dis. 23(9):1145–1151.
  • Nielsen MB, Çolak Y, Benn M, Nordestgaard BG. 2021. Low plasma adiponectin in risk of type 2 diabetes: observational analysis and one- and two-sample mendelian randomization analyses in 756,219 individuals. Diabetes. 70(11):2694–2705.
  • Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, et al. 2015. 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 74(10):1789–1798.
  • Qu Y, Wu J, Deng JX, Zhang YP, Liang WY, Jiang ZL, Yu QH, Li J. 2016. MicroRNA-126 affects rheumatoid arthritis synovial fibroblast proliferation and apoptosis by targeting PIK3R2 and regulating PI3K-AKT signal pathway. Oncotarget. 7(45):74217–74226.
  • Qiao L, Zou C, van der Westhuyzen DR, Shao J. 2008. Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes. 57(7):1824–1833.
  • Rasheed H, Hsu A, Dalbeth N, Stamp LK, McCormick S, Merriman TR. 2014. The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout. Arthritis Res Ther. 16(6):495.
  • Sun GH, Liu J, Wan L, Fang YY, Long Y, Zhang Y, Bao BX. 2021. Effect of Huangqin Qingre Chubi capsule-containing serum on the expression of miR-23a-3p/PTEN after co-culture of CD4+ T cells and cardiomyocytes in gouty arthritis. Bei Jing Zhong Yi Yao Da Xue Xue Bao. 44:735–743.
  • Sun GH, Liu J, Wan L, Liu W, Long Y, Bao BX, Zhang Y. 2021. A preliminary study on effect of Huangqin Qingre Chubi capsule in improving acute inflammation of acute gouty arthritis based on serum proteomics. Zhong Cao Yao. 52:3061–3067.
  • Schlesinger N, Thiele RG. 2010. The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis. 69(11):1907–1912.
  • Sharonova L, Verbovoj A, Canava I, Verbovaja N. 2016. The influence of adiponectin and leptin levels on myocardial remodeling in patients with type 2 diabetes mellitus and gout. Klin Med. 94(2):120–127.
  • Shermane Lim YW, Xiang X, Garg M, Le MT, Li-Ann Wong A, Wang L, Goh BC. 2021. The double-edged sword of H19 lncRNA: insights into cancer therapy. Cancer Lett. 500:253–262.
  • Ton J, Kolber MR. 2020. Targeting uric acid levels in treating gout. Can Fam Physician. 66(9):671–671.
  • Wang X, Chang J, Zhou G, Cheng C, Xiong Y, Dou J, Cheng G, Miao C. 2021. The Traditional Chinese Medicine compound Huangqin Qingre Chubi capsule inhibits the pathogenesis of rheumatoid arthritis through the CUL4B/Wnt pathway. Front Pharmacol. 12:750233.
  • Wang Y, Liu J, Huang CB, Zong RK, Li M. 2014. Clinical observation on oral and external administration of TCM herbs for 30 cases of acute attack of gouty arthritis with damp-heat stasis obstruction syndrome. Zhong Yi Za Zhi. 55:1299–1302.
  • Wang B, Suen CW, Ma H, Wang Y, Kong L, Qin D, Lee Y, Li G. 2020. The roles of H19 in regulating inflammation and aging. Front Immunol. 11:579687.
  • Xue YY, Liu HJ, Sun ZJ, Xiang T, Shao P. 2022. H19 is involved in the regulation of inflammatory responses in acute gouty arthritis by targeting miR-2-3p. Immunol Res. 70(3):392–399.
  • Xu YJ, Wei RS, Li XH, Li Q, Yu JR, Zhuang XF. 2022. MiR-421 promotes lipid metabolism by targeting PTEN via activating PI3K/AKT/mTOR pathway in non-small cell lung cancer. Epigenomics. 14(3):121–138.
  • Zhai KF, Duan H, Cui CY, Cao YY, Si JL, Yang HJ, Wang YC, Cao WG, Gao GZ, Wei ZJ. 2019. Liquiritin from Glycyrrhiza uralensis attenuating rheumatoid arthritis via reducing inflammation, suppressing angiogenesis, and inhibiting MAPK signaling pathway. J Agric Food Chem. 67(10):2856–2864.
  • Zhai K, Duan H, Wang W, Zhao S, Khan GJ, Wang M, Zhang Y, Thakur K, Fang X, Wu C, et al. 2021. Ginsenoside Rg1 ameliorates blood-brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release. Acta Pharm Sin B. 11(11):3493–3507.
  • Zhang XH, Liu J, Zhou Q, Chen XL, Ding X. 2020. Changes of lipid metabolism and its correlation with immune, inflammatory indexes and uric acid in patients with gouty arthritis. Feng Shi Bing Yu Guan Jie Yan. 10:1–5.
  • Zhang XH, Liu J, Zhou Q, Ding X, Chen XL. 2021. Effects of Huangqin Qingrejiebi capsule on biochemical indexes of patients with gout complicated with hyperlipidemia based on data mining. Hu Nan Zhong Yi Yao Da Xue Xue Bao. 41:1389–1394.
  • Zhang QB, Zhu D, Wen Z, Yi T, Li Q, Qing YF, Zhou JG. 2019. High levels of serum uric acid, cystain C and lipids concentration and their clinical significance in primary gouty arthritis patients. Curr Rheumatol Rev. 15(2):141–145.